1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 656 F.Supp.2d
  5. 656 F.Supp.2d 729 (2009)
 

NOVO NORDISK A/S v. CARACO PHARMACEUTICAL LAB.

Case No. 05-40188.

656 F.Supp.2d 729 (2009)

NOVO NORDISK A/S and Novo Nordisk, Inc., Plaintiffs, v. CARACO PHARMACEUTICAL LABORATORIES, LTD. and Sun Pharmaceutical Industries, Ltd., Defendants.

United States District Court, E.D. Michigan, Southern Division.

September 24, 2009.

Attorney(s) appearing for the Case

Josh A. Krevitt, Gibson, Dunn & Crutcher LLP, New York, NY, Michael A. Sitzman, Gibson, Dunn & Crutcher LLP, San Francisco, CA, Michelle L. Alamo, Dickinson Wright, Detroit, MI, for Plaintiffs.

Charles B. Klein, Winston & Strawn, Washington, D.C., David S. Bloch, Winson & Strawn, San Francisco, CA, Morley Witus, Barris, Sott, Denn & Driker, Detroit, MI, for Defendants.

DECISION RE: DOC. 318

AVERN COHN, District Judge.

This is a patent case involving the drug repaglinide marketed by Novo Nordisk (Novo) under the trade name Prandin. Now before the Court is Caraco Pharmaceutical Laboratories' (Caraco) Motion for Summary Judgment on Count IV of Its Third Amended Counterclaim and Sixth Affirmative Defense for Patent Misuse (Dkt. 318). The background of the case as well as Caraco's motion is described in the Court's decisions...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases